USE OF NITROUS OXIDE, ARGON, XENON, HELIUM, OR NEON, FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULTS IN PATIENTS WHO CANNOT BE TREATED WITH THROMBOLYTIC AGENTS

摘要

The present invention relates to the use of at least one gas selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents, such as the human recombinant form of tissue-type plasminogen activator (rt-PA).